Get CEUs at 75% Savings. 35 CEUs for $85. Compared to regular price of $340 for 35 CEUs.
For seventy years, the American Diabetes Association published scholarly journals and ground-breaking articles. The American Diabetes Association is the authoritative voice in diabetes research and standards of care. Annual Review of Diabetes 2020 contains more than 40 of the ADA’s finest articles published in 2019. Get the year’s most current and important research in this one comprehensive book. These journal articles are compiled by the American Diabetes Association (ADA), the largest non-profit organization leading to prevent and cure diabetes.
Summary:
- Iatrogenic Hyperinsulinemia, Not Hyperglycemia, Drives Insulin Resistance in Type 1 Diabetes as Revealed by Comparison With GCK-MODY (MODY2)
- A Network Analysis of Biomarkers for Type 2 Diabetes
- Digital Therapeutics: Leading the Way to Improved Outcomes for People with Diabetes
- Using Flash Continuous Glucose Monitoring in Primary Practice
- Cardiovascular Outcome Trials in Type 2 Diabetes: What Do They Mean for Clinical Practice?
- A Developmental Milestones Map of Type 1 Diabetes Self-Management Transition From Parents to Adolescents
- Targeting BCAA Catabolism to Treat Obesity-Associated Insulin Resistance
- Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
- Long-Term Effects of Metformin on Diabetes Prevention: Identification of Subgroups That Benefited Most in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study
- The Legacy Effect in Type 2 Diabetes: Impact of Early Glycemic Control on Future Complications (The Diabetes & Aging Study)